DISEASE INDICATIONS: Risk of cardiovascular events
MANUFACTURER: Novartis
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Entresto is a combination medication used to treat chronic heart failure in adults, containing sacubitril and valsartan.
CHARACTERISTICS
ACTIVE HALF-LIFE 14-16 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE 250-600 MG/WEEK
HEPATOTOXICITY LOW
AROMATIZATION MEDIUM
ACTIVE SUBSTANCE BOLDENONE UNDECYLENATE, TESTOSTERONE ENANTHATE
FORM 10 ML X 400 MG/ML
MANUFACTURER DRAGON PHARMA
CHARACTERISTICS
ACTIVE HALF-LIFE 14 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 400-1000 MG/WEEK
ACNE RARELY
WATER RETENTION LOW
HBR NO
HEPATOTOXICITY LOW
AROMATIZATION LOW
ACTIVE SUBSTANCE BOLDENONE UNDECYLENATE
FORM 10 ML X 300 MG/ML
MANUFACTURER DRAGON PHARMA
CHARACTERISTICS
ACTIVE HALF-LIFE 14 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 400-1000 MG/WEEK
ACNE RARELY
WATER RETENTION LOW
HBR NO
HEPATOTOXICITY LOW
AROMATIZATION LOW
ACTIVE SUBSTANCE BOLDENONE UNDECYLENATE
FORM 10 ML X 500 MG/ML
MANUFACTURER DRAGON PHARMA
CHARACTERISTICS
ACTIVE HALF-LIFE 4-6 HOURS
CLASSIFICATION PDE5 INHIBITOR
DOSAGE MEN 100 MG/DAY
ACNE NO
WATER RETENTION NO
HBR POSSIBLE
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE SILDENAFIL
FORM 4 PILLS X 100 MG
MANUFACTURER RANBAXY
Active Ingredient and Capacity
Somatropin(recombinant human growth hormone) 36IU
Appearance & Packaging Unit
A dose-adjustable pen-type injection with a transparent cartridge containing a colorless or light yellow solution (Minimum adjustable volume is 0.5IU)
36IU : 36IU/1.69mL pen x 1 pc./box
Storage
In a hermetic container, keep refrigerated (2~8℃).
